JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705020200 on July 16, 2007

J. Biol. Chem., Vol. 282, Issue 37, 26802-26809, September 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/37/26802    most recent
M705020200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrita, L. D.
Right arrow Articles by Bottomley, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrita, L. D.
Right arrow Articles by Bottomley, S. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Aeropin from the Extremophile Pyrobaculum aerophilum Bypasses the Serpin Misfolding Trap*

Lisa D. Cabrita{ddagger}12, James A. Irving{ddagger}13, Mary C. Pearce{ddagger}, James C. Whisstock{ddagger}§4, and Stephen P. Bottomley{ddagger}5

From the {ddagger}Department of Biochemistry and Molecular Biology, Monash University, Victoria 3800, Australia and §ARC Centre of Excellence for Structural and Function Microbial Genomics, Monash University, Clayton 3800, Australia

Serpins are metastable proteinase inhibitors. Serpin metastability drives both a large conformational change that is utilized during proteinase inhibition and confers an inherent structural flexibility that renders serpins susceptible to aggregation under certain conditions. These include point mutations (the basis of a number of important human genetic diseases), small changes in pH, and an increase in temperature. Many studies of serpins from mesophilic organisms have highlighted an inverse relationship: mutations that confer a marked increase in serpin stability compromise inhibitory activity. Here we present the first biophysical characterization of a metastable serpin from a hyperthermophilic organism. Aeropin, from the archaeon Pyrobaculum aerophilum, is both highly stable and an efficient proteinase inhibitor. We also demonstrate that because of high kinetic barriers, aeropin does not readily form the partially unfolded precursor to serpin aggregation. We conclude that stability and activity are not mutually exclusive properties in the context of the serpin fold, and propose that the increased stability of aeropin is caused by an unfolding pathway that minimizes the formation of an aggregation-prone intermediate ensemble, thereby enabling aeropin to bypass the misfolding fate observed with other serpins.


Received for publication, June 19, 2007 , and in revised form, July 9, 2007.

* This work was supported by the Australian Research Council and the NHMRC. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 National Health and Medical Research Council Australia (NHMRC) CJ Martin Fellows. These authors contributed equally to this work.

2 Present address: Dept. of Chemistry, Cambridge University, Cambridge CB2 1EW, UK.

3 Present address: Dept. of Structural Biology, Wellcome Trust Centre for Human Genetics, Oxford University, Oxford OX3 7BN, UK.

5 A Senior Research Fellow of the NHMRC. To whom correspondence may be addressed. Tel.: 61399053703; Fax: 6199054699; E-mail: steve.bottomley{at}med.monash.edu.au.

4 A Principal Research Fellow of the NHMRC and a Monash University Senior Logan Fellow. To whom correspondence may be addressed. Tel.: 61399053747; Fax:6199053726; E-mail: james.whisstock{at}med.monash.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.